Supernus Pharmaceuticals Inc.
SUPN | NASDAQ
$43.61
+$0.83 (+1.94%)
Sep 22, 2026, 10:37 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 830.44M | 776.83M | 718.95M | 681.54M | 665.13M | 668M | 661.82M | 651.97M | 630.16M | 597.4M | 607.52M | 610.54M | 634.01M | 668.5M | 667.24M | 658.96M | 630.07M | 601.35M | 579.78M | 564.28M | 570.95M | 556.35M |
Cost of Revenue | 99.03M | 82.19M | 74.56M | 77.65M | 76.27M | 77.36M | 77.91M | 71.44M | 73.45M | 76.63M | 83.78M | 87.11M | 93.38M | 92.75M | 87.22M | 81.26M | 73.47M | 78.04M | 75.06M | 76.6M | 79.9M | 63.26M |
Gross Profit | 731.41M | 694.64M | 644.39M | 603.89M | 588.85M | 590.64M | 583.91M | 580.54M | 556.71M | 520.77M | 523.74M | 523.43M | 540.63M | 575.75M | 580.02M | 577.7M | 556.6M | 523.31M | 504.71M | 487.68M | 491.05M | 493.09M |
Operating Income | -111.81M | -41.71M | -44.52M | -36.94M | 64.14M | 74.56M | 81.67M | 59.27M | 26.56M | -13.6M | -5.27M | 30.06M | 20.4M | 49.33M | 46.12M | 17.89M | 52.02M | 74.78M | 86.03M | 122.93M | 146.47M | 157.9M |
Interest Income | 9.31M | 11.21M | 13.25M | 16.21M | 18.03M | 17.23M | 16.2M | 13.21M | 10.87M | 8.5M | 10.45M | 10.87M | 11.92M | 12.34M | 21.69M | 21.18M | 20.65M | 21.46M | 10.57M | 14.4M | 14.78M | 16.34M |
Pretax Income | -123.47M | -49.15M | -49.03M | -20.73M | 82.16M | 91.8M | 97.87M | 72.48M | 37.42M | -6.01M | 2.77M | 36.92M | 26.59M | 55.04M | 60.74M | 27.65M | 57.06M | 76.97M | 73.18M | 110.82M | 134.57M | 150.54M |
Net Income | -109.89M | -29.02M | -38.55M | -19.12M | 64.5M | 61.91M | 73.87M | 59.71M | 5.24M | -15.51M | 1.32M | 25.62M | 43.35M | 52.04M | 60.71M | 37.67M | 57.49M | 73.35M | 53.42M | 81.75M | 100.19M | 111.13M |
Selling & General & Admin | 560.88M | 520.79M | 485.56M | 442.58M | 332.66M | 325.01M | 321.58M | 323.46M | 336.4M | 337.28M | 336.36M | 329.05M | 358.67M | 372.36M | 377.22M | 404.98M | 364.7M | 333.76M | 304.76M | 259.32M | 241.75M | 220.32M |
Research & Development | 126.09M | 118.75M | 106.24M | 107.06M | 106.73M | 110.79M | 108.8M | 103.5M | 97.12M | 95.31M | 91.59M | 86.02M | 82.92M | 74.93M | 74.55M | 77.86M | 77.96M | 77.03M | 90.47M | 87.33M | 84.51M | 91.3M |
Other Expenses | 157.14M | 97.71M | 97.12M | 91.19M | 85.34M | 80.27M | 71.87M | 94.32M | 96.64M | 101.78M | 101.06M | 78.3M | 78.64M | 79.13M | 82.12M | 76.97M | 61.93M | 37.74M | 23.46M | 18.1M | 18.32M | 23.57M |
Operating Expenses | 844.11M | 737.24M | 688.91M | 640.83M | 524.72M | 516.07M | 502.25M | 521.27M | 530.15M | 534.37M | 529.01M | 493.37M | 520.23M | 526.41M | 533.89M | 559.81M | 504.59M | 448.53M | 418.69M | 364.75M | 344.59M | 335.19M |
Interest Expense | 2.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 910K | 2.42M | 4.01M | 5.73M | 6.63M | 7.07M | 11.41M | 15.61M | 19.27M | 23.42M | 23.59M | 23.75M | 24.1M |
Selling & Marketing Expenses | 253.03M | 225.37M | 288.65M | 260.06M | 237.33M | 231M | 227.29M | 227.98M | 230.43M | 231.52M | 229.19M | 221.9M | 250.82M | 264.51M | 267.79M | 281.98M | 246.98M | 221.78M | 199.71M | 174.12M | 161.55M | 141.77M |
Cost & Expenses | 942.25M | 818.54M | 763.48M | 718.48M | 600.99M | 593.43M | 580.15M | 592.71M | 603.61M | 611M | 612.79M | 580.47M | 613.61M | 619.16M | 621.11M | 641.07M | 578.06M | 526.57M | 493.75M | 441.35M | 424.49M | 398.45M |
Income Tax Expense | -13.58M | -20.13M | -10.48M | -1.62M | 17.67M | 29.88M | 24.01M | 12.77M | 32.19M | 9.5M | 1.45M | 11.3M | -16.76M | 2.99M | 32K | -10.02M | -427K | 3.62M | 19.75M | 29.07M | 34.38M | 39.42M |
Shares Outstanding (Basic) | 58.07M | 57.65M | 57.34M | 56.4M | 56.02M | 55.86M | 55.47M | 55.15M | 54.98M | 54.8M | 54.57M | 54.61M | 54.5M | 54.38M | 54.1M | 53.79M | 53.43M | 53.33M | 53.24M | 53.19M | 53.01M | 52.93M |
Shares Outstanding (Diluted) | 58.07M | 57.65M | 57.34M | 56.55M | 56.64M | 55.86M | 56.46M | 56.02M | 55.72M | 55.63M | 55.06M | 54.61M | 54.5M | 62.45M | 62.09M | 55.03M | 61.4M | 61.41M | 54.53M | 54.33M | 54.72M | 54.2M |
EPS (Basic) | -1.92 | -0.51 | -0.68 | -0.33 | 1.17 | 1.13 | 1.34 | 1.08 | 0.09 | -0.29 | 0.02 | 0.47 | 0.79 | 0.96 | 1.13 | 0.71 | 1.09 | 1.39 | 1.02 | 1.55 | 1.90 | 2.11 |
EPS (Diluted) | -1.92 | -0.51 | -0.68 | -0.34 | 1.15 | 1.11 | 1.32 | 1.07 | 0.09 | -0.29 | 0 | 0.41 | 0.73 | 0.89 | 1.03 | 0.64 | 1.01 | 1.30 | 0.98 | 1.51 | 1.85 | 2.07 |
EBITDA | -15.87M | 51.75M | 49.34M | 67.89M | 166.09M | 166.99M | 165.71M | 143.14M | 109.85M | 75.42M | 90.04M | 124.96M | 116.27M | 146.45M | 153.36M | 116.47M | 134.97M | 143.6M | 129.19M | 159.81M | 184.89M | 197.64M |
EBIT | -117.58M | -45.58M | -42.23M | -17.5M | 85.4M | 86.94M | 85.29M | 59.9M | 24.85M | -9.59M | 5.18M | 40.93M | 32.32M | 61.67M | 67.81M | 39.06M | 72.67M | 96.24M | 96.6M | 134.4M | 158.32M | 174.64M |
Depreciation & Amortization | 101.71M | 97.32M | 91.56M | 85.39M | 80.69M | 80.05M | 80.41M | 83.25M | 85M | 85.01M | 84.86M | 84.03M | 83.95M | 84.78M | 85.54M | 77.4M | 62.3M | 47.37M | 32.6M | 25.41M | 26.58M | 23M |
Add to Watchlist
Select watchlists to add or remove SUPN